New Drug Dossier

Click here to subscribe

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. 

Webcast

Entry kit available online February 11

The time is almost here to enter the industry's most distinguished awards program. MM&M Awards honor exceptional creativity and marketing effectiveness in healthcare. With a wide range of categories, you're sure to find the perfect fit to showcase your best work. Visit www.mmm-online.com/awards for more information and to download your entry kit.      

TOP JOBS

To find out about the MM&M Careers Section contact:
Scott Dattoli at 646-638-6015

Subscribe Today


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

MM&M Career & Salary Survey Premium Edition

Are you making as much as your peers?

Complete the MM&M Career & Salary Survey 2008 now for a chance to win the latest Nintendo console. All responses will remain confidential. Click here to take the survey. 

 


The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Medical education needs a new policeman: report

A group of heavyweights in medical education says the CME profession needs a new accreditation authority.
 

Vytorin study's a stinker

Zetia doesn't even move the needle.
 

Pfizer seeks to win over local CME providers with revamped grant portal

A major funder of CME is trying to win back accredited education providers who may have been turned off by pharma's newer grant application systems.
 

Tysabri approved as Crohn's treatment

The FDA today approved Elan and Biogen IDEC's supplemental biologics license application for Tysabri to treat Crohn's disease, a chronic and progressive disease marked by inflammation of the bowel.
 

MAHF to honor industry stalwarts Feb. 12 in New York

The Medical Advertising Hall of Fame (MAHF) will induct Robert Baldini, John Corcoran and Richard Cliggott at a special celebration dinner on February 12 at the Pierre Hotel in New York City. The MAHF will also honor Audrey Girard with a lifetime achievement award and M. James Dougherty with a service to industry award.
 

In Brief

Product news

Novo Nordisk discontinued its experimental AERx inhaler and took a charge of $260 million in 2007, saying the product offered little clinical benefit.
 

People news

Roche has appointed of Steven Sembler VP of commercial operations for Roche in Nutley, NJ, where he will oversee US marketing and sales for products in a number of key therapeutic areas including oncology, HIV, hepatitis and anti-infectives.
 

Company news

Nature Publishing Group (NPG) and online physician community Sermo announced a partnership to facilitate the discussion and interpretation of content in leading NPG medical journals by US physicians.
 

Latest Features

MM&M All-Stars Company of the Year: Merck

When the going got tough, Merck got back to basics.
 

MM&M All-Stars Large Pharma Marketing Team of the Year: Cymbalta (Eli Lilly)

Eli Lilly & Co. spent $128 million promoting Cymbalta (duloxetene) for the year through August, according to IMS Health.
 

MM&M All-Stars Small Pharma Marketing Team of the Year: Keppra (UCB, Inc.)

Since last year, when UCB, Inc. let users of its antiepileptic Keppra speak for the brand, patients have become an important visual and vocal component in all promotion.
 

MM&M All-Stars Agency of the Year: AbelsonTaylor

Uncommonly good creative has helped standalone agency AbelsonTaylor stand out among its peers, garner acclaim and earn loyalty from clients.
 

MM&M All-Stars Media Brand of the Year: Sermo

On September 20, 2007, Sermo's founder and CEO Dr. Daniel Palestrant stepped up to the podium at the Health 2.0 conference in San Francisco and in less than three minutes summarized how his brainchild, an online community for physicians launched just a year earlier, has forever changed the healthcare media landscape.
 

Beyond the Patent: Extending the Life of Brands

With many of the industry's major blockbuster drugs coming off-patent in the next few years, pharmaceutical companies are scrambling to extend the life of their biggest brands. Larry Friedman, PhD, offers some potential solutions based on brand architecture and flow of brand equity
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.